))
From The Heart - (SGLT2 inhibitors) Ep#3: From diabetes to heart failure!
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on April 04, 2024 11:08 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 337666494 series 3322188
Treść dostarczona przez RAS LSS Consulting. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez RAS LSS Consulting lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
Today’s podcast is the third in the series of five episodes of “From The Heart - Tying the threads through the evolving body of evidence in HF “. Today's episode is focused on a new class of drugs in heart failure - The Sodium Glucose Like Transporter 2 inhibitors or as they are more commonly known as SGLT2is
For those who have just tuned in to our podcast series for the first time, please do listen into our first episode where we discussed about the basics of heart failure and a brief historical view of heart failure therapies (Link https://www.buzzsprout.com/1947788/10351733-from-the-heart-ep-1-introduction-to-heart-failure-and-a-brief-overview-of-evolving-hf-treatments.mp3?download=true)
The second episode discussed about Entresto, its mechanism of action and clinical evidence in heart failure. (Link https://www.buzzsprout.com/1947788/10498068-from-the-heart-ep-2-entresto-the-first-arni-approved-for-heart-failure.mp3?download=true)
7 odcinków
Udostępnij
